Meet with... The National Cancer Institute SBIR Development Center

Sep 20 2016

Program Overview:
Meet with... The National Cancer Institute SBIR Development Center

Program Director Dr. Xing-Jian Lou will present and discuss the SBIR and STTR programs that fund and support small biomedical technology companies.

Presentation will cover:

◦     Overview of SBIR/STTR eligibility requirements

◦     NIH SBIR/STTR process and new cancer-focused grant funding opportunities from NCI

◦     New NCI Funding Opportunities in priority research areas 

◦     NCI SBIR/STTR initiatives such as the expanded I-Corps™ at NIH Program

◦     Practical strategies on how to successfully submit competitive research proposals

10:00 AM | Registration & Networking session
10:30 AM | Presentation & Q&A
11:50 AM | Networking Lunch
1:00-4:30 PM | One-on-one Meetings*

In addition, Dr. Lou will be holding one-on-one meetings with pre-approved companies. Registration is available online [link needed]. Please send a one-page (PDF preferred) executive summary to by September 13, 5PM ET to be considered for a one-on-one meeting.

National Cancer Institute Participating Representative:
Dr. Xing-Jian Lou | Program Director, Small Business Innovation Research Development Center, National Cancer Institute read bio»

About the National Cancer Institute:
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice. The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

Presentation & Lunch:
$25 | General Public
$35 | General Public - At the door
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until May 18th (or full).

One-on-One Meetings:
FREE | Application
FREE | Accepted Companies

John P. McGovern Campus
2450 Holcombe Blvd, Suite J
Houston, TX 77021

Parking Information:
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.

National Cancer Institute Participating Representative's Biography:
Xing-Jian Lou

Dr. Xing-Jian Lou | Program Director, Small Business Innovation Research Development Center, National Cancer Institute
Dr. Xing-Jian Lou is a Program Director in the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute (NCI). In this role, she actively engages in identifying areas of interest for NCI to develop Contract Topics and Funding Opportunity Announcements. She also conducts outreach events to help recruit more focused, commercially-minded SBIR applicants, and coaches small businesses to develop stronger applications and obtain government funding for innovative research and development projects with high commercial potential. Dr. Lou manages funded projects, mentoring and guiding companies throughout the award period, and facilitating their interaction with potential third-party investors and strategic partners. Dr. Lou has over 15 years experience in research and product development in the area of biomarker-, assay-, technology- and knowledgebase- development for diagnosis and drug development. Prior to joining NCI she held a variety of scientific and management positions in pharmaceutical and biotech companies, including Johnson & Johnson, LumiCyte, Applied Biosystems (now part of Thermo Fisher Scientific corporation) and diaDexus. Dr. Lou received her PhD degree in Molecular & Cellular Pharmacology from the Miller Medical School of the University of Miami and completed her postdoctoral training at Stanford University.
Connect with Xing: Connect on LinkedIn

About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Thomas McNerney & Partners, NCATS, Poliwogg, and OrbiMed.